Hai Robotics Joins the United Nations Global Compact
4.9.2023 06:01:00 EEST | Business Wire | Press release
Hai Robotics, a global leading provider of autonomous case-handling robots (ACR) systems, is proud to announce that it has joined the United Nations Global Compact initiative—the world's largest voluntary corporate sustainability initiative.
Hai Robotics joins thousands of organizations across 160 countries that are committed to taking responsible business action to build a more sustainable and inclusive society. Hai Robotics commits to uphold the Ten Principles of the UN Global Compact and support the UN in achieving the Sustainable Development Goals (SDG). Hai Robotics will also share an annual Communication on Progress to showcase its continued engagement.
"At Hai Robotics, we view sustainability as crucial in driving our long-term growth and resilience, and strive to serve as a responsible corporate citizen for our stakeholders," said Richie Chen, Founder and CEO at Hai Robotics. "We are excited to join the UN Global Compact in its mission to accelerate corporate sustainability. As a company continuing to expand globally, we recognize the growing importance of incorporating ESG increasingly into our business strategy. Participating in the UN Global Compact is critical in the improvement of our sustainability efforts during the development of warehouse automation solutions."
Hai Robotics is actively involved in reducing its environmental footprint through sustainable business practices and production methods. Hai Robotics implements action in sustainable sourcing to hold itself accountable across all stages of the supply chain, such as the use of composite wood in packaging. With this new commitment, Hai Robotics will evaluate its existing ESG activities and support for clients to ensure they align with UN's Sustainable Development Goals and create positive impact. For more information on Hai's ESG efforts and commitment, click here to access our annual sustainability report.
As the largest corporate sustainability initiative in the world, the UN Global Compact consists of more than 15,000 companies and 3,800 non-business signatories across over 160 countries, and more than 69 Local Networks. The Sustainable Development Goals consist of 17 global goals aimed to tackle societal issues and improve the quality of life by 2030, covering five key areas of people, planet, prosperity, peace and partnership.
About Hai Robotics
Hai Robotics, a leading global provider of Autonomous Case-handling Robot (ACR) systems, is committed to providing flexible, intelligent, and efficient warehouse automation solutions through robotics technology and AI algorithms. The HaiPick solution, independently developed in 2015, is the world's first ever ACR solution. Hai Robotics is a global enterprise that has more than 1,000 projects worldwide and serves customers from more than 30 countries and regions. We have offices to cover the United States, Europe, Japan, South Korea, Southeast Asia and Australia. We strive to combine global experience with local expertise to provide our customers with tailored, quality solutions. Hai Robotics is also a Participant of the United Nations Global Compact and adhere to its principles-based approach to responsible business. To learn more about Hai Robotics, visit www.hairobotics.com/
About the United Nations Global Compact
As a special initiative of the UN Secretary-General, the United Nations Global Compact is a call to companies everywhere to align their operations and strategies with Ten Principles in the areas of human rights, labour, environment and anti-corruption. Our ambition is to accelerate and scale the global collective impact of business by upholding the Ten Principles and delivering the Sustainable Development Goals through accountable companies and ecosystems that enable change. With more than 15,000 companies and 3,000 non-business signatories based in over 160 countries, and 69 Local Networks, the UN Global Compact is the world’s largest corporate sustainability initiative — one Global Compact uniting business for a better world. For more information, follow @globalcompact on social media and visit our website at unglobalcompact.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230903281684/en/
Contact information
Jennifer Kang
jennifer.kang@hairobotics.com
pr@hairobotics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
